News Related to Focal Epilepsy

Related coverage linked through entity extraction aliases.

Biotech Startups Tortugas Neuroscience and Korsana Biosciences Launch with $281 Million for Neurological Disorders

Jul 23, 2026

Tortugas Neuroscience and Korsana Biosciences emerged with significant funding to advance clinical-stage pipelines targeting neurological and neurodegenerative diseases. Tortugas raised $106 million, while Korsana secured $175 million to develop therapies for conditions including Alzheimer's, schizophrenia, and epilepsy.

FDA Clears First-in-Human Trial of Allogeneic Cell Therapy for Drug-Resistant Epilepsy

Mar 14, 2026

The FDA has authorized the first human trial of an allogeneic stem cell therapy for epilepsy, developed by Shanghai-based Unixell Biotechnology. The therapy uses donor-derived stem cells to produce GABA and suppress seizures in drug-resistant patients.